| Item Type | Name |
|
Concept
|
Clinical Competence
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Ethics, Clinical
|
|
Academic Article
|
Hope and the limits of research.
|
|
Academic Article
|
Learning from our patients: one participant's impact on clinical trial research and informed consent.
|
|
Academic Article
|
Study of cohort-specific consent and patient control in phase I cancer trials.
|
|
Academic Article
|
Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.
|
|
Academic Article
|
Ethical issues in the development of new agents.
|
|
Academic Article
|
Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.
|
|
Academic Article
|
Informed consent, the cancer patient, and phase I clinical trials.
|
|
Academic Article
|
Referral and decision making among advanced cancer patients participating in Phase I trials at a single institution.
|
|
Academic Article
|
Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials.
|
|
Academic Article
|
American oncologists' views of internet use by cancer patients: a mail survey of American Society of Clinical Oncology members.
|
|
Academic Article
|
Overcoming obstacles to hospice care: an ethical examination of inertia and inaction.
|
|
Academic Article
|
Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents.
|
|
Academic Article
|
Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
|
|
Academic Article
|
Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
|
|
Academic Article
|
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
|
|
Academic Article
|
Ethical issues in phase I clinical trials.
|
|
Academic Article
|
Physician preferences and knowledge regarding the care of childhood cancer survivors in Japan: a mailed survey of the Japanese Society of Pediatric Oncology.
|
|
Academic Article
|
Pushing the envelope: informed consent in phase I trials.
|
|
Academic Article
|
An intervention to improve cancer patients' understanding of early-phase clinical trials.
|
|
Academic Article
|
Perceptions of cancer patients and their physicians involved in phase I trials.
|
|
Academic Article
|
Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials.
|
|
Academic Article
|
Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation.
|
|
Academic Article
|
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
|
|
Academic Article
|
Hope, decision making, and use of the internet and other media among cancer clinical trials participants.
|
|
Academic Article
|
A study of informed consent (IC), age, and cognitive performance (CP) among advanced cancer patients (acp) in phase I trials.
|
|
Academic Article
|
Interest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients.
|
|
Academic Article
|
Survival and informed consent understanding of elderly advanced cancer patients enrolling in phase I trials.
|
|
Academic Article
|
What advanced cancer patients with limited treatment options know about clinical research: a qualitative study.
|
|
Academic Article
|
Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?
|
|
Academic Article
|
Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials.
|
|
Academic Article
|
Is it ethical to enroll a patient in a hepatitis C virus clinical trial when current standard of care is highly effective and safe?
|
|
Academic Article
|
Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.
|
|
Academic Article
|
Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers.
|
|
Academic Article
|
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
|
|
Grant
|
Ethics and Clinical Trials in Advanced Cancer Care
|